Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-010518
Filing Date
2024-03-19
Accepted
2024-03-19 17:26:00
Documents
111
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2620647
2 ex4-1.htm EX-4.1 180100
3 ex10-46.htm EX-10.46 53435
4 ex21-1.htm EX-21.1 7501
5 ex23-1.htm EX-23.1 5597
6 ex31-1.htm EX-31.1 18675
7 ex31-2.htm EX-31.2 18749
8 ex32-1.htm EX-32.1 8034
9 ex32-2.htm EX-32.2 7909
10 ex97.htm EX-97.1 41514
  Complete submission text file 0001493152-24-010518.txt   12838235

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE hrow-20231231.xsd EX-101.SCH 81928
12 XBRL CALCULATION FILE hrow-20231231_cal.xml EX-101.CAL 110318
13 XBRL DEFINITION FILE hrow-20231231_def.xml EX-101.DEF 398882
14 XBRL LABEL FILE hrow-20231231_lab.xml EX-101.LAB 657847
15 XBRL PRESENTATION FILE hrow-20231231_pre.xml EX-101.PRE 538951
115 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2309729
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 24765115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)